Skip to main content
Livermore
Livermore
ZHEN

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

13F holders, Q3 2021

Institutional positions in DMK Pharmaceuticals Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
+2 vs. Q2 2021
Shares held
15.1M
−1.08M (−6.7%) vs. Q2 2021
Total value
$14.6M
−$3.15M (−17.7%) vs. Q2 2021
New holders
7
13 more added
Sold out
5
8 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 53 institutions
Q1 2021: 53 institutionsQ2 2021: 51 institutionsQ3 2021: 53 institutionsQ4 2021: 49 institutionsQ1 2022: 46 institutionsQ2 2022: 45 institutionsQ3 2022: 43 institutionsQ4 2022: 48 institutionsQ1 2023: 47 institutionsQ2 2023: 22 institutionsQ3 2023: 25 institutionsQ4 2023: 29 institutionsQ1 2024: 3 institutionsQ2 2024: 2 institutionsQ3 2024: 2 institutionsQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2021: $14.6M
Q1 2021: $11.8MQ2 2021: $17.8MQ3 2021: $14.6MQ4 2021: $8.58MQ1 2022: $7.38MQ2 2022: $6.44MQ3 2022: $2.55MQ4 2022: $2.16MQ1 2023: $3.20MQ2 2023: $276.4KQ3 2023: $178.7KQ4 2023: $350.4KQ1 2024: $4Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding DMK and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20252$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20241$0
Q3 20242$0
Q2 20242$0
Q1 20243$4
Q4 202329$350.4K
Q3 202325$178.7K
Q2 202322$276.4K
Q1 202347$3.20M
Q4 202248$2.16M
Q3 202243$2.55M
Q2 202245$6.44M
Q1 202246$7.38M
Q4 202149$8.58M
Q3 202153$14.6M
Q2 202151$17.8M
Q1 202153$11.8M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding DMK Pharmaceuticals Corp; share changes are against Q2 2021.

Institutions holding DMK in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Winch Advisory Services, LLC73$00.00%00.0%Unchanged
RVW Wealth, LLC19,000$00.00%00.0%Unchanged
Heritage Wealth Management, LLC6$00.00%+6New
Wells Fargo & Company913$1.00K0.00%−45−4.7%Reduced
Signaturefd, LLC863$1.00K0.00%00.0%Unchanged
Harbour Investments, Inc.2,000$2.00K0.00%00.0%Unchanged
Allworth Financial LP3,530$3.00K0.00%00.0%Unchanged
Coastal Capital Group, Inc.5,100$5.00K0.00%00.0%Unchanged
Hexagon Capital Partners LLC5,000$5.00K0.00%00.0%Unchanged
Firestone Capital Management5,200$6.00K0.00%00.0%Unchanged
Barclays PLC7,347$8.00K0.00%+1,824+33.0%Added
Wolff Wiese Magana LLC10,740$10.0K0.01%00.0%Unchanged
We Are One Seven, LLC10,615$11.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.11,671$11.0K0.00%+2,500+27.3%Added
Jane Street Group, LLC11,152$11.0K0.00%+11,152New
Oppenheimer & Co Inc12,000$12.0K0.00%00.0%Unchanged
Squarepoint Ops LLC13,224$13.0K0.00%−100,964−88.4%Reduced
Bank of America Corp12,951$13.0K0.00%+1,881+17.0%Added
Affinity Capital Advisors, LLC13,180$13.0K0.00%+13,180New
Raymond James & Associates16,246$16.0K0.00%+4,638+40.0%Added
Founders Capital Management18,000$17.0K0.01%00.0%Unchanged
Royal Bank of Canada20,000$19.0K0.00%+20,000New
Victory Capital Management Inc21,664$21.0K0.00%−1,093−4.8%Reduced
Stonebridge Capital Advisors LLC22,000$21.0K0.00%00.0%Unchanged
Global Strategic Investment Solutions, LLC23,000$22.0K0.00%00.0%Unchanged
Credit Suisse AG24,850$24.0K0.00%+24,850New
JPMorgan Chase & Co26,170$25.0K0.00%−16,730−39.0%Reduced
National Asset Management, Inc.25,210$25.0K0.00%00.0%Unchanged
Principal Financial Group Inc27,866$27.0K0.00%−4,518−14.0%Reduced
Prelude Capital Management, LLC28,489$28.0K0.00%−69,101−70.8%Reduced
Avantax Advisory Services, Inc.32,000$31.0K0.00%00.0%Unchanged
Regions Financial Corp34,500$33.0K0.00%00.0%Unchanged
Lido Advisors, LLC46,721$45.0K0.00%00.0%Unchanged
UBS Group AG50,000$49.0K0.00%−9,709−16.3%Reduced
Tower Research Capital LLC (TRC)50,872$49.0K0.00%+24,076+89.8%Added
Charles Schwab Investment Management Inc56,257$55.0K0.00%00.0%Unchanged
Atom Investors LP56,492$55.0K0.01%+56,492New
Cambridge Investment Research Advisors, Inc.64,849$63.0K0.00%00.0%Unchanged
HighTower Advisors, LLC69,050$66.0K0.00%+56,850+466.0%Added
Bank of New York Mellon Corp84,002$81.0K0.00%00.0%Unchanged
Citadel Advisors LLC90,771$88.0K0.00%+68,476+307.1%Added
Edmond de Rothschild Holding S.A.100,000$97.0K0.00%00.0%Unchanged
Morgan Stanley104,950$102.0K0.00%+2,405+2.3%Added
Verdence Capital Advisors LLC143,382$139.0K0.02%00.0%Unchanged
Virtu Financial LLC204,870$199.0K0.02%+204,870New
Northern Trust Corp258,851$251.0K0.00%00.0%Unchanged
Greenlight Capital Inc292,366$283.0K0.02%−707,634−70.8%Reduced
State Street Corp420,205$408.0K0.00%00.0%Unchanged
Millennium Management LLC557,157$540.0K0.00%+541,460+3,449.4%Added
Geode Capital Management, LLC1,333,913$1.29M0.00%+47,774+3.7%Added
Susquehanna International Group, LLP1,377,545$1.34M0.00%+490,645+55.3%Added
BlackRock Inc.2,744,412$2.66M0.00%+1,914+0.1%Added
Vanguard Group Inc6,509,454$6.32M0.00%+195,613+3.1%Added
Balyasny Asset Management LLC0$00.00%−1,622,510−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−241,991−100.0%Sold out
Hayden Royal, LLC0$00.00%−40,015−100.0%Sold out
Natixis0$00.00%−38,600−100.0%Sold out
Bessemer Group Inc0$00.00%−1,000−100.0%Sold out